Valproic acid-induced eosinophilic pleural effusion: A case report and review of the literature

American Journal of the Medical Sciences

Volumn 333, Issue 5, 2007, Pages 290-292

  Bullington, Wendy ^a   Sahn, Steven A ^b   Judson, Marc A ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Eosinophilia; Pleural effusion; Toxicity; Valproic acid

Indexed keywords

VALPROIC ACID;

ADULT; AFRICAN AMERICAN; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; EOSINOPHILIA; HEMATOTHORAX; HUMAN; MALE; PARASITOSIS; PLEURA EFFUSION; PNEUMOTHORAX; THORAX RADIOGRAPHY;

ADULT; EOSINOPHILIA; HUMANS; MALE; PLEURAL EFFUSION; VALPROIC ACID;

EID: 34249112616     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31805339ae     Document Type: Article

References (20)

1. Rubins JB, Rubin HB. Etiology and prognostic significance of eosinophilic pleural effusions: a prospective study. Chest 1996;110:1271-74.
2. Huggins JT, Sahn SA. Drug induced pleural disease. Clin Chest Med 2004;25:151-3.
3. Rinne UK. Pleuropulmonary changes during long-term bromocriptine treatment for Parkinson's disease. Lancet 1981;1:44.
4. Mahoney JM, Bachtel MD. Pleural effusion associated with chronic dantrolene administration. Ann Pharmacother 1994;28:587-9.
5. Behnia M, Dowdeswell I, Vakili S. Pleural fluid and serum eosinophilia: association with fluoxetine hydrochloride. South Med J 2000;93:611-3.
6. Tzanakis N, Bouros D, Siarakas N. Eosinophilic pleural effusion associated due to gliclazide. Resp Med 2000;94:94.
7. Milleron BJ Valcke J, Akoun GM, et al. Isotretinoinrelated eosinophilic pleural effusion [letter]. Chest 1996;110:1128.
8. Trisolini R, Dore R, Biagi F, et al. Eosinophilic pleural effusion due to mesalamine: report of a rare occurrence. Sarcoidosis Vasc Diffuse 2000;17:288-91.
9. Rosenow ED III, DeRemee RA, Dines DE. Chronic nitrofurantoin pulmonary reactions: report of 5 cases. N Engl J Med 1968;279:1258-62.
10. Middleton KL, Santella R, Couser JI Jr. Eosinophilic pleuritis due to propylthiouracil. Chest 1993;103:955-6.
11. Watanabe H, Anayama S, Horiuchi T, et al. Pleural effusion caused by prostaglandin E1 preparation. Chest 2002;123:952-3.
12. Moufarrege G, Frank E, Carstens D. Eosinophilic exudative pleural effusion after initiation of tizanidine treatment: a case report. Pain Medicine 2003;4:85-90.
13. Kaufman J, O'Shaughnessy IM. Eosinophilic pleural effusion associated with valproic acid administration. South Med J 1995;88:881-2.
14. Shaib FH, Patel B. A case of eosinophilic pleural effusion secondary to valproic acid. Chest 2000;117:613.
15. Tonnelier JM, Mocquard Y, Broch C, et al. Febrile pleuropericarditis during valproic acid treatment [in French]. Presse Med 2001;30:62-3.
16. Kravetz JD, Federman DG. Valproic acid-induced eosinophilic pleural effusion. South Med J 2003;96:803-5.
17. Catalan AA, Sanchez PM, Domezain del Campo MR, et al. Eosinophilic pleural effusion secondary to treatment with valproic acid. Actas Espanolas De Psiquiatria 2005;33:401-2.
18. Debourdeau PM, Djezzar S, Estival JL, et al. Life-threatening eosinophilic pleuropericardial effusion related to vitamins B5 and H. Ann Pharmacother 2001;35:424-6.
19. Antony VB. Drug-induced pleural disease. Clin Chest Med 1998;19:331-40.
20. Naranjo CA, Busto U, Sellers EM, et al. A method of estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.